ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung - 
66135001 Janssen-Cilag AG
Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung02.06.2017
  02.06.2017
Ustekinumab (L04AC05) 
WHO-DDD 
07.15. 
07.15. 
B  
Yes 
IP 
3074.64Yes
    
10 %3360.25
7680661350015Biotechnologika
7136323 
Composition
ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, methioninum, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 2.5 µg/ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Ustekinumabum130mg / 26ml
BAG: Active AgentDose
Ustekinumabum130 mg
 
Inactive agents
Dinatrii Edetas
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Saccharum
 
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home